Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Mol Psychiatry ; 26(12): 7188-7199, 2021 12.
Article in English | MEDLINE | ID: mdl-34193974

ABSTRACT

Dopamine plays a crucial role in adaptive behavior, and dysfunctional dopamine is implicated in multiple psychiatric conditions characterized by inflexible or inconsistent choices. However, the precise relationship between dopamine and flexible decision making remains unclear. One reason is that, while many studies have focused on the activity of dopamine neurons, efficient dopamine signaling also relies on clearance mechanisms, notably the dopamine transporter (DAT), which predominates in striatum, and catechol-O-methyltransferase (COMT), which predominates in cortex. The exact locus, extent, and timescale of the effects of DAT and COMT are uncertain. Moreover, there is limited data on how acute disruption of either mechanism affects flexible decision making strategies mediated by cortico-striatal networks. To address these issues, we combined pharmacological modulation of DAT and COMT with electrochemistry and behavior in mice. DAT blockade, but not COMT inhibition, regulated sub-second dopamine release in the nucleus accumbens core, but surprisingly neither clearance mechanism affected evoked release in prelimbic cortex. This was not due to a lack of sensitivity, as both amphetamine and atomoxetine changed the kinetics of sub-second release. In a multi-step decision making task where mice had to respond to reversals in either reward probabilities or the choice sequence to reach the goal, DAT blockade selectively impaired, and COMT inhibition improved, performance after reward reversals, but neither manipulation affected the adaptation of choices after action-state transition reversals. Together, our data suggest that DAT and COMT shape specific aspects of behavioral flexibility by regulating different aspects of the kinetics of striatal and cortical dopamine, respectively.


Subject(s)
Catechol O-Methyltransferase , Dopamine , Animals , Catechol O-Methyltransferase/genetics , Catechol O-Methyltransferase/metabolism , Corpus Striatum/metabolism , Dopamine Plasma Membrane Transport Proteins/metabolism , Kinetics , Mice , Nucleus Accumbens/metabolism
2.
J Exp Biol ; 222(Pt 5)2019 03 08.
Article in English | MEDLINE | ID: mdl-30850509

ABSTRACT

The evolutionary conservation of neural mechanisms for forming and maintaining pair bonds is unclear. Oxytocin, vasopressin and dopamine (DA) transmitter systems have been shown to be important in pair-bond formation and maintenance in several vertebrate species. We examined the role of dopamine in formation of song preference in zebra finches, a monogamous bird. Male courtship song is an honest signal of sexual fitness; thus, we measured female song preference to evaluate the role of DA in mate selection and pair-bond formation, using an operant conditioning paradigm. We found that DA acting through the D2 receptor, but not the D1 receptor, can induce a song preference in unpaired female finches and that blocking the D2 receptor abolished song preference in paired females. These results suggest that similar neural mechanisms for pair-bond formation are evolutionarily conserved in rodents and birds.


Subject(s)
Avian Proteins/genetics , Courtship , Dopamine/metabolism , Receptors, Dopamine D1/genetics , Receptors, Dopamine D2/genetics , Songbirds/physiology , Vocalization, Animal , Animals , Avian Proteins/metabolism , Conditioning, Operant , Female , Finches/physiology , Receptors, Dopamine D1/metabolism , Receptors, Dopamine D2/metabolism
3.
Nat Commun ; 10(1): 3075, 2019 07 12.
Article in English | MEDLINE | ID: mdl-31300665

ABSTRACT

The brain has a remarkable capacity to adapt to changes in sensory inputs and to learn from experience. However, the neural circuits responsible for this flexible processing remain poorly understood. Using optogenetic silencing of ArchT-expressing neurons in adult ferrets, we show that within-trial activity in primary auditory cortex (A1) is required for training-dependent recovery in sound-localization accuracy following monaural deprivation. Because localization accuracy under normal-hearing conditions was unaffected, this highlights a specific role for cortical activity in learning. A1-dependent plasticity appears to leave a memory trace that can be retrieved, facilitating adaptation during a second period of monaural deprivation. However, in ferrets in which learning was initially disrupted by perturbing A1 activity, subsequent optogenetic suppression during training no longer affected localization accuracy when one ear was occluded. After the initial learning phase, the reweighting of spatial cues that primarily underpins this plasticity may therefore occur in A1 target neurons.


Subject(s)
Auditory Cortex/physiology , Learning/physiology , Sound Localization/physiology , Acoustic Stimulation , Animals , Auditory Cortex/cytology , Female , Ferrets , Models, Animal , Nerve Net/physiology , Neuronal Plasticity/physiology , Neurons/physiology , Optogenetics
4.
Nat Commun ; 10(1): 336, 2019 01 18.
Article in English | MEDLINE | ID: mdl-30659189

ABSTRACT

To date, the spatiotemporal release of specific neurotransmitters at physiological levels in the human brain cannot be detected. Here, we present a method that relates minute-by-minute fluctuations of the positron emission tomography (PET) radioligand [11C]raclopride directly to subsecond dopamine release events. We show theoretically that synaptic dopamine release induces low frequency temporal variations of extrasynaptic extracellular dopamine levels, at time scales of one minute, that can evoke detectable temporal variations in the [11C]raclopride signal. Hence, dopaminergic activity can be monitored via temporal fluctuations in the [11C]raclopride PET signal. We validate this theory using fast-scan cyclic voltammetry and [11C]raclopride PET in mice during chemogenetic activation of dopaminergic neurons. We then apply the method to data from human subjects given a palatable milkshake and discover immediate and-for the first time-delayed food-induced dopamine release. This method enables time-dependent regional monitoring of stimulus-evoked dopamine release at physiological levels.


Subject(s)
Dopamine/metabolism , Neurons/metabolism , Raclopride/metabolism , Animals , Brain/metabolism , Brain/surgery , Eating , Electric Stimulation , Electrodes , Female , Humans , Male , Mice , Models, Biological , Positron-Emission Tomography/methods , Radioligand Assay , Temporal Lobe/metabolism , Temporal Lobe/surgery , Time Factors
5.
Neuropsychopharmacology ; 41(13): 3060-3069, 2016 12.
Article in English | MEDLINE | ID: mdl-27388330

ABSTRACT

Catechol-O-methyltransferase (COMT) modulates dopamine levels in the prefrontal cortex. The human gene contains a polymorphism (Val158Met) that alters enzyme activity and influences PFC function. It has also been linked with cognition and anxiety, but the findings are mixed. We therefore developed a novel mouse model of altered COMT activity. The human Met allele was introduced into the native mouse COMT gene to produce COMT-Met mice, which were compared with their wild-type littermates. The model proved highly specific: COMT-Met mice had reductions in COMT abundance and activity, compared with wild-type mice, explicitly in the absence of off-target changes in the expression of other genes. Despite robust alterations in dopamine metabolism, we found only subtle changes on certain cognitive tasks under baseline conditions (eg, increased spatial novelty preference in COMT-Met mice vs wild-type mice). However, genotype differences emerged after administration of the COMT inhibitor tolcapone: performance of wild-type mice, but not COMT-Met mice, was improved on the 5-choice serial reaction time task after tolcapone administration. There were no changes in anxiety-related behaviors in the tests that we used. Our findings are convergent with human studies of the Val158Met polymorphism, and suggest that COMT's effects are most prominent when the dopamine system is challenged. Finally, they demonstrate the importance of considering COMT genotype when examining the therapeutic potential of COMT inhibitors.


Subject(s)
Catechol O-Methyltransferase/genetics , Catechol O-Methyltransferase/metabolism , Cognition Disorders/genetics , Disease Models, Animal , Methionine/genetics , Polymorphism, Single Nucleotide/genetics , Analysis of Variance , Animals , Benzophenones/pharmacology , Benzophenones/therapeutic use , Brain/drug effects , Brain/metabolism , Catechol O-Methyltransferase Inhibitors/pharmacology , Catechol O-Methyltransferase Inhibitors/therapeutic use , Choice Behavior/drug effects , Cognition Disorders/drug therapy , Cognition Disorders/metabolism , Exploratory Behavior/drug effects , Genotype , Maze Learning/drug effects , Mice , Mice, Transgenic , Nitrophenols/pharmacology , Nitrophenols/therapeutic use , Reaction Time/drug effects , Reaction Time/genetics , Tolcapone , Valine/genetics
6.
Channels (Austin) ; 5(6): 461-3, 2011.
Article in English | MEDLINE | ID: mdl-21785269

ABSTRACT

The synaptic changes induced by initial drug exposure leave a trace on neural systems that can eventually manifest in compulsive drug-seeking behavior. A single injection of cocaine has been shown to induce a change in the AMPA receptor (AMPAR) subunit composition at glutamatergic synapses onto ventral tegmental area (VTA) dopamine (DA) neurons. This change is long-lasting (up to months following self-administration) and represents an important functional change at the synaptic level following cocaine use. We recently published findings that cocaine's action at the DA transporter (DAT) is necessary for the induction of AMPAR redistribution and that this can also be mimicked by selective DA neuron stimulation. The stimulation effect is dependent on D1 receptors within the VTA. Furthermore other addictive drugs, although they act through distinct mechanisms, also induce this synaptic change. Here we discuss literature that expands on these observations in an attempt to further clarify the synaptic changes following early drug use.


Subject(s)
Cocaine-Related Disorders/metabolism , Cocaine , Dopaminergic Neurons/metabolism , Receptors, Dopamine D1/metabolism , Receptors, Glutamate/metabolism , Synapses/metabolism , Animals , Cocaine/adverse effects , Cocaine/pharmacokinetics , Cocaine/pharmacology , Humans
SELECTION OF CITATIONS
SEARCH DETAIL